|
MTHFD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.035100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.097550E-03 |
| Normal-vs-Stage2 |
1.398840E-01 |
| Normal-vs-Stage3 |
3.430200E-01 |
| Normal-vs-Stage4 |
3.052300E-02 |
| Stage1-vs-Stage2 |
7.600000E-01 |
| Stage1-vs-Stage3 |
9.663500E-03 |
| Stage1-vs-Stage4 |
6.294600E-01 |
| Stage2-vs-Stage3 |
3.195800E-01 |
| Stage2-vs-Stage4 |
5.852600E-01 |
| Stage3-vs-Stage4 |
8.749800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.155600E-03 |
| Normal-vs-AfricanAmerican |
3.073200E-01 |
| Normal-vs-Asian |
7.189600E-02 |
| Caucasian-vs-AfricanAmerican |
4.45510000000038E-05 |
| Caucasian-vs-Asian |
7.926200E-01 |
| AfricanAmerican-vs-Asian |
1.080490E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.844100E-02 |
| Normal-vs-Female |
1.420540E-03 |
| Male-vs-Female |
2.324600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.717730E-03 |
| Normal-vs-Age(41-60Yrs) |
9.618200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.036410E-01 |
| Normal-vs-Age(81-100Yrs) |
1.464450E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.682200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.202200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.014400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.103400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.156800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.621600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.088400E-01 |
| Classical-VS-Follicular |
4.376800E-01 |
| Classical-VS-Other |
5.964100E-02 |
| Classical-VS-Normal |
9.405300E-04 |
| Tall-VS-Follicular |
4.945200E-01 |
| Tall-VS-Other |
2.065200E-01 |
| Tall-VS-Normal |
3.097800E-02 |
| Follicular-VS-Other |
2.652400E-01 |
| Follicular-VS-Normal |
1.695570E-01 |
| Other-VS-Normal |
9.357400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.290400E-02 |
| Normal-vs-N1 |
7.169700E-02 |
| N0-vs-N1 |
9.702000E-01 |
|
|
